Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Circulation. Cardiovascular Quality and Outcomes|November 14, 2019
Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA TrialJonathan D Newman, Karen P Alexander, Xiangqiong Gu, et al.
American Heart Journal|May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and designGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
The New England Journal of Medicine|April 1, 2020
Health-Status Outcomes with Invasive or Conservative Care in Coronary DiseaseJohn A Spertus, Philip G Jones, David J Maron, et al.
Journal of the American College of Cardiology|March 26, 2025
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA TrialDavid J Maron, Jonathan D Newman, Rebecca Anthopolos, et al.
Nature Medicine|July 15, 2020
Myocardial infarction accelerates breast cancer via innate immune reprogrammingGraeme J Koelwyn, Alexandra A C Newman, Milessa S Afonso, et al.
Circulation|September 9, 2021
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia SeverityHarmony R Reynolds, Leslee J Shaw, James K Min, et al.
JACC. Cardiovascular Interventions|January 25, 2023
Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD TrialMandeep S Sidhu, Karen P Alexander, Zhen Huang, et al.
European Heart Journal|August 5, 2024
Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trialNick S Nurmohamed, James K Min, Rebecca Anthopolos, et al.
European Heart Journal|September 13, 2021
Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trialJose L Lopez-Sendon, Derek D Cyr, Daniel B Mark, et al.
Pageof 11